|
1
|
Eslam M, Sanyal AJ and George J:
International Consensus Panel. MAFLD: A consensus-driven proposed
nomenclature for metabolic associated fatty liver disease.
Gastroenterology. 58:1999–2014, e1. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Younossi ZM, Koenig AB, Abdelatif D, Fazel
Y, Henry L and Wymer M: Global epidemiology of nonalcoholic fatty
liver disease-Meta-analytic assessment of prevalence, incidence,
and outcomes. Hepatology. 64:73–84. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Estes C, Anstee QM, Arias-Loste MT, Bantel
H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day
CP, et al: Modeling NAFLD disease burden in China, France, Germany,
Italy, Japan, Spain, United Kingdom, and United States for the
period 2016-2030. J Hepatol. 69:896–904. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Oda K, Uto H, Mawatari S and Ido A:
Clinical features of hepatocellular carcinoma associated with
nonalcoholic fatty liver disease: A review of human studies. Clin J
Gastroenterol. 8:1–9. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tateishi R, Uchino K, Fujiwara N, Takehara
T, Okanoue T, Seike M, Yoshiji H, Yatsuhashi H, Shimizu M, Torimura
T, et al: A nationwide survey on non-B, non-C hepatocellular
carcinoma in Japan: 2011-2015 update. J Gastroenterol. 54:367–376.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dulai PS, Singh S, Patel J, Soni M, Prokop
LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, et al:
Increased risk of mortality by fibrosis stage in nonalcoholic fatty
liver disease: Systematic review and meta-analysis. Hepatology.
65:1557–1565. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Angulo P, Kleiner DE, Dam-Larsen S, Adams
LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC,
Lafferty HD, Stahler A, et al: Liver fibrosis, but no other
histologic features, is associated with long-term outcomes of
patients with nonalcoholic fatty liver disease. Gastroenterology.
149:389–397, e10. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yoshimine Y, Uto H, Kumagai K, Mawatari S,
Arima S, Ibusuki R, Mera K, Nosaki T, Kanmura S, Numata M, et al:
Hepatic expression of the Sptlc3 subunit of serine
palmitoyltransferase is associated with the development of
hepatocellular carcinoma in a mouse model of nonalcoholic
steatohepatitis. Oncol Rep. 33:1657–1666. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chalasani N, Younossi Z, Lavine JE,
Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM and Sanyal AJ:
The diagnosis and management of nonalcoholic fatty liver disease:
Practice guidance from the American association for the study of
liver diseases. Hepatology. 67:328–357. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
European Association for the Study of the
Liver (EASL); European Association for the Study of Diabetes
(EASD); European Association for the Study of Obesity (EASO).
EASL-EASD-EASO clinical practice guidelines for the management of
non-alcoholic fatty liver disease. J Hepatol. 64:1388–1402.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sterling RK, Lissen E, Clumeck N, Sola R,
Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT,
Thomas DL, et al: Development of a simple noninvasive index to
predict significant fibrosis in patients with HIV/HCV coinfection.
Hepatology. 43:1317–1325. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono
M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, et al:
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver
disease population. BMC Gastroenterol. 12(2)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lee J, Vali Y, Boursier J, Spijker R,
Anstee QM, Bossuyt PM and Zafarmand MH: Prognostic accuracy of
FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A
systematic review. Liver Int. 41:261–270. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kruger FC, Daniels CR, Kidd M, Swart G,
Brundyn K, Van Rensburg C and Kotze M: APRI: A simple bedside
marker for advanced fibrosis that can avoid liver biopsy in
patients with NAFLD/NASH. S Afr Med J. 101:477–480. 2011.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nishikoba N, Kumagai K, Kanmura S,
Nakamura Y, Ono M, Eguchi H, Kamibayashiyama T, Oda K, Mawatari S,
Tanoue S, et al: HGF-MET signaling shifts M1 macrophages toward an
M2-like phenotype through PI3K-mediated induction of Arginase-1
Expression. Front Immunol. 11(2135)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tabassum R, Rämö JT, Ripatti P, Koskela
JT, Kurki M, Karjalainen J, Palta P, Hassan S, Nunez-Fontarnau J,
Kiiskinen TTJ, et al: Genetic architecture of human plasma lipidome
and its link to cardiovascular disease. Nat Commun.
10(4329)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hornemann T, Wei Y and von Eckardstein A:
Is the mammalian serine palmitoyltransferase a high-molecular-mass
complex? Biochem J. 405:157–164. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hornemann T, Richard S, Rütti MF, Wei Y
and von Eckardstein A: Cloning and initial characterization of a
new subunit for mammalian serine-palmitoyltransferase. J Biol Chem.
281:37275–37281. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Menaldino DS, Bushnev A, Sun A, Liotta DC,
Symolon H, Desai K, Dillehay DL, Peng Q, Wang E, Allegood J, et al:
Sphingoid bases and de novo ceramide synthesis: Enzymes involved,
pharmacology and mechanisms of action. Pharmacol Res. 47:373–381.
2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zheng W, Kollmeyer J, Symolon H, Momin A,
Munter E, Wang E, Kelly S, Allegood JC, Liu Y, Peng Q, et al:
Ceramides and other bioactive sphingolipid backbones in health and
disease: Lipidomic analysis, metabolism and roles in membrane
structure, dynamics, signaling and autophagy. Biochim Biophys Acta.
1758:1864–1884. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gomez-Larrauri A, Presa N,
Dominguez-Herrera A, Ouro A, Trueba M and Gomez-Muñoz A: Role of
bioactive sphingolipids in physiology and pathology. Essays
Biochem. 64:579–589. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kolak M, Westerbacka J, Velagapudi VR,
Wågsäter D, Yetukuri L, Makkonen J, Rissanen A, Häkkinen AM,
Lindell M, Bergholm R, et al: Adipose tissue inflammation and
increased ceramide content characterize subjects with high liver
fat content independent of obesity. Diabetes. 56:1960–1968.
2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cinar R, Godlewski G, Liu J, Tam J,
Jourdan T, Mukhopadhyay B, Harvey-White J and Kunos G: Hepatic
cannabinoid-1 receptors mediate diet-induced insulin resistance by
increasing de novo synthesis of long-chain ceramides. Hepatology.
59:143–153. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lee YS, Choi KM, Choi MH, Ji SY, Lee S,
Sin DM, Oh KW, Lee YM, Hong JT, Yun YP, et al: Serine
palmitoyltransferase inhibitor myriocin induces growth inhibition
of B16F10 melanoma cells through G(2)/M phase arrest. Cell Prolif.
44:320–329. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lee YS, Choi KM, Lee S, Sin DM, Lim Y, Lee
YM, Hong JT, Yun YP and Yoo HS: Myriocin, a serine
palmitoyltransferase inhibitor, suppresses tumor growth in a murine
melanoma model by inhibiting de novo sphingolipid synthesis. Cancer
Biol Ther. 13:92–100. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ordoñez R, Fernández A, Prieto-Domínguez
N, Martínez L, García-Ruiz C, Fernández-Checa JC, Mauriz JL and
González-Gallego J: Ceramide metabolism regulates autophagy and
apoptotic cell death induced by melatonin in liver cancer cells. J
Pineal Res. 59:178–189. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hagström H, Nasr P, Ekstedt M, Hammar U,
Stål P, Hultcrantz R and Kechagias S: Fibrosis stage but not NASH
predicts mortality and time to development of severe liver disease
in biopsy-proven NAFLD. J Hepatol. 67:1265–1273. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Loomba R and Chalasani N: The hierarchical
model of NAFLD: Prognostic significance of histologic features in
NASH. Gastroenterology. 149:278–281. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tokushige K, Hashimoto E, Yatsuji S,
Tobari M, Taniai M, Torii N and Shiratori K: Prospective study of
hepatocellular carcinoma in nonalcoholic steatohepatitis in
comparison with hepatocellular carcinoma caused by chronic
hepatitis C. J Gastroenterol. 45:960–967. 2010.PubMed/NCBI View Article : Google Scholar
|
